About Cresilon
Cresilon is a Technology company based in New York (United States) founded in 2010. Developer of hemostatic products for wound care. It operates in the Technology and Healthcare sectors. Cresilon has raised $113.35 million across 8 funding rounds from investors including Paulson Investment Company. Cresilon offers products and services including VETIGEL and TRAUMAGEL. Its focus areas include High Tech, Nanotechnology, Nanoenabled Products and Life Science. Its legal entity is CRESILON, INC. Its competitors include Imbed Biosciences, Alafair Biosciences and Solsys Medical; 3 of its 3 listed competitors have raised funding.
Company details
Cresilon was founded in 2010 and is based in New York, United States. Operations focus on the medical device sector, where hemostatic gels and devices are developed to control bleeding. VETIGEL, a prescription gel kit, is provided for moderate to severe bleeds in animals only. TRAUMAGEL serves as a temporary device for external traumatic bleeding unsuitable for tourniquets in humans.
- Total Equity Funding$113.35M (USD)
in 8 rounds
- Investors
Products & Services of Cresilon
Cresilon offers a comprehensive portfolio of products and services, including VETIGEL and TRAUMAGEL.
Gel that stops bleeding in animals within seconds.
Gel for controlling bleeding in human trauma situations.
Apps and channels of Cresilon
its YouTube channel Cresilon, Inc. has 131 subscribers and 3 videos.
Videos from Cresilon
The most watched videos on Cresilon's YouTube channel, Cresilon, Inc. (131 subscribers). Click a video to play it here.
More on Cresilon, Inc..
Funding Insights of Cresilon
Cresilon has successfully raised a total of $113.35M across 8 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $113.35M
- Total Rounds 8
- First Round $1.63M
(Nov 2016)
- Investors Count 1
All 8 funding rounds of Cresilon with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr 2026 | $5M | Series B | – | – | – |
| Nov 2025 | $6.68M | Series B | – | – | – |
| Apr 2024 | $25M | Series B | – | – | – |
| Aug 2023 | $17.24M | Series A | – | – | – |
| Oct 2022 | $25M | Series A | – | Paulson Investment | – |
| Feb 2021 | $24.46M | Series A | – | – | – |
| Jan 2018 | $13.34M | Series A | – | – | – |
| Nov 2016 | $1.63M | Seed | – | – | – |
1 investors in total: 1 institutional.
Investors in Cresilon
Cresilon has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Paulson Investment Company.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Investment banking services are provided for small to mid-cap markets. | 1970 | paulsoninvestment.com | Portland, United States |
Investor details for Cresilon
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Cresilon
23 people are tracked at Cresilon (14 in leadership, 9 in team).
| Name | Role | Group |
|---|---|---|
Scott Levine | Chief Financial Officer | Leadership |
Omar Ahmad | Director, Product & Portfolio Management | Leadership |
Isaac Miller | EVP & Co-Founder | Leadership |
Cidnee Vaykovich | Vice President, Business Development | Leadership |
Karthik Eticala | VP, Manufacturing Operations | Leadership |
Joe Landolina | CEO & Co-Founder | Leadership |
Hassaan Ahmad | VP, Quality & Regulatory Affairs | Leadership |
Irene Dris | VP, Technology | Leadership |
凯蒂 黄 | Project Director | Leadership |
Karthik E. | Vice President, Manufacturing & Supply Chain | Leadership |
Namita Pandita | Director, Quality | Leadership |
Shelby Strauss | Director Of Engineering | Leadership |
Sandra Salazar | Quality Assurance Operations And Compliance Director | Leadership |
Karina Duffy | Head of People | Leadership |
Stephanie Leveen | Corporate Controller | Team |
Lesbeth Roque | R&d Engineer I | Team |
Ellen Merry | R&d Formulation Intern | Team |
Sandra Ferree | Process Engineer II | Team |
Kyle Schepis | Quality Engineer II | Team |
Kevin Ambrose | Manufacturing Production Lead | Team |
3 more people are available in the full profile.
Complete people profiles for Cresilon
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Cresilon
3 dated milestones of Cresilon across 16 years, from founding to its latest funding, stage changes and deals.
- Founded Cresilon is founded.
- Funding First funding round of $1.6M.
- Funding Latest funding round, Series B,.
Competitors of Cresilon
Cresilon has 3 listed competitors in our database, 3 of them funded. They include Imbed Biosciences, Alafair Biosciences and Solsys Medical.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| imbedbio.com | 2010 | Madison, United States | $22.7M | 35 | Nanotech-based wound care products are developed and provided. | |
| alafairbiosciences.com | 2011 | Austin, United States | $13.74M | Biomaterials and devices for internal wound healing are developed. | ||
| solsysmedical.com | 1999 | Norfolk, United States | $29.55M | Human skin allografts and dressings for wound care are supplied. |
Detailed competitors of Cresilon
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Cresilon
The website of Cresilon (cresilon.com) receives about 9.1K visits a month.
- Monthly visits9.1K
▲ 31.9% vs previous month
Websites whose visitors overlap most with Cresilon. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| life-assist.com | 100% | #682,818 | View details | ||
| google.com | 26% | 85.8B | #1 | View details |
Top companies in Nanotechnology
3 companies that operate in the same segment as Cresilon (Nanotechnology) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of technologies for analysis of genetic variation and function | 1993 | San Diego, California, United States | USD 28 M | USD 1.44 M | 29 | |
RNA interference-based therapeutics are developed for multiple disorders. | 2002 | Cambridge, Massachusetts, United States | USD 17 M | USD 3.71 B | 2,230 | |
Aerogel-based thermal insulation solutions are provided for energy conservation. | 2001 | United States | USD 198.35 M | USD 271.1 M | 554 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Cresilon
Complete news archive for Cresilon
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Cresilon
Cresilon was founded in 2010 and raised its 1st funding round 6 years after it was founded.
Cresilon is headquartered in New York, United States. It is registered at New York, New York, United States.
Cresilon is a funded company, having raised a total of $113.35M across 8 funding rounds to date. The company's 1st funding round was a Seed of $1.63M, raised on Nov 2016.
Cresilon was founded in 2010 and is based in New York, United States. Operations focus on the medical device sector, where hemostatic gels and devices are developed to control bleeding. VETIGEL, a prescription gel kit, is provided for moderate to severe bleeds in animals only. TRAUMAGEL serves as a temporary device for external traumatic bleeding unsuitable for tourniquets in humans.
Cresilon's top competitors include Imbed Biosciences, Alafair Biosciences and Solsys Medical.
Cresilon offers VETIGEL and TRAUMAGEL.
Cresilon has 1 investor. Key investors include Paulson Investment Company.
Cresilon operates through Cresilon, Inc..